Cargando…
Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting: hovering among bleeding risk, thromboembolic events, and stent thrombosis
Dual antiplatelet treatment with aspirin and clopidogrel is the antithrombotic treatment recommended after an acute coronary syndrome and/or coronary artery stenting. The evidence for optimal antiplatelet therapy for patients, in whom long-term treatment oral anticoagulation is mandatory, is however...
Autores principales: | Menozzi, Mila, Rubboli, Andrea, Manari, Antonio, De Palma, Rossana, Grilli, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502192/ https://www.ncbi.nlm.nih.gov/pubmed/23075316 http://dx.doi.org/10.1186/1477-9560-10-22 |
Ejemplares similares
-
Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation After Coronary Stent Implantation
por: Jang, Sung-Won, et al.
Publicado: (2011) -
ANMCO position paper on antithrombotic treatment of patients with atrial fibrillation undergoing intracoronary stenting and/or acute coronary syndromes
por: De Luca, Leonardo, et al.
Publicado: (2022) -
Triple Therapy When Thrombotic Risk Exceeds Bleeding Risk: Polycythemia Vera in a Patient With Atrial Fibrillation and Subacute Stent Thrombosis
por: Aksoy, Elif, et al.
Publicado: (2019) -
Antithrombotic management of patients with acute coronary syndrome and atrial fibrillation undergoing coronary stenting: a prospective, observational, nationwide study
por: De Luca, Leonardo, et al.
Publicado: (2020) -
Antithrombotic treatment switching in elderly patients with atrial fibrillation and the risk of thromboembolism, bleeding, and cardiac death
por: Ehrlinder, Hanne, et al.
Publicado: (2022)